Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309211092> ?p ?o ?g. }
- W4309211092 endingPage "14039" @default.
- W4309211092 startingPage "14039" @default.
- W4309211092 abstract "A high salt (HS) diet is associated with an increased risk for cardiovascular diseases (CVDs) and fibrosis is a key contributor to the organ dysfunction involved in CVDs. The activation of the renin angiotensin type 2 receptor (AT2R) has been considered as organ protective in many CVDs. However, there are limited AT2R-selective agonists available. Our first reported β-substituted angiotensin III peptide, β-Pro7-AngIII, showed high selectivity for the AT2R. In the current study, we examine the potential anti-fibrotic and anti-inflammatory effects of this novel AT2R-selective peptide on HS-induced organ damage. FVB/N mice fed with a 5% HS diet for 8 weeks developed cardiac and renal fibrosis and inflammation, which were associated with increased TGF-β1 levels in heart, kidney and plasma. Four weeks’ treatment (from weeks 5–8) with β-Pro7-AngIII inhibited the HS-induced cardiac and renal fibrosis and inflammation. These protective effects were accompanied by reduced local and systemic TGF-β1 as well as reduced cardiac myofibroblast differentiation. Importantly, the anti-fibrotic and anti-inflammatory effects caused by β-Pro7-AngIII were attenuated by the AT2R antagonist PD123319. These results demonstrate, for the first time, the cardio- and reno-protective roles of the AT2R-selective β-Pro7-AngIII, highlighting it as an important therapeutic that can target the AT2R to treat end-organ damage." @default.
- W4309211092 created "2022-11-24" @default.
- W4309211092 creator A5003642180 @default.
- W4309211092 creator A5009687649 @default.
- W4309211092 creator A5021580042 @default.
- W4309211092 creator A5026923125 @default.
- W4309211092 creator A5029379615 @default.
- W4309211092 creator A5059828833 @default.
- W4309211092 creator A5069729257 @default.
- W4309211092 creator A5070440854 @default.
- W4309211092 creator A5078998685 @default.
- W4309211092 date "2022-11-14" @default.
- W4309211092 modified "2023-10-17" @default.
- W4309211092 title "The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice" @default.
- W4309211092 cites W1512110535 @default.
- W4309211092 cites W1532347262 @default.
- W4309211092 cites W1959096812 @default.
- W4309211092 cites W1974279158 @default.
- W4309211092 cites W1974562777 @default.
- W4309211092 cites W1988502601 @default.
- W4309211092 cites W1992418679 @default.
- W4309211092 cites W1994135647 @default.
- W4309211092 cites W1997001062 @default.
- W4309211092 cites W2001391676 @default.
- W4309211092 cites W2014145970 @default.
- W4309211092 cites W2015505701 @default.
- W4309211092 cites W2016193552 @default.
- W4309211092 cites W2018492901 @default.
- W4309211092 cites W2020481425 @default.
- W4309211092 cites W2025458195 @default.
- W4309211092 cites W2032368194 @default.
- W4309211092 cites W2033457930 @default.
- W4309211092 cites W2035653659 @default.
- W4309211092 cites W2035812542 @default.
- W4309211092 cites W2044987386 @default.
- W4309211092 cites W2049533449 @default.
- W4309211092 cites W2050928977 @default.
- W4309211092 cites W2088988158 @default.
- W4309211092 cites W2096280264 @default.
- W4309211092 cites W2101345537 @default.
- W4309211092 cites W2101683630 @default.
- W4309211092 cites W2107359871 @default.
- W4309211092 cites W2110815706 @default.
- W4309211092 cites W2112903359 @default.
- W4309211092 cites W2113301098 @default.
- W4309211092 cites W2116230802 @default.
- W4309211092 cites W2119577709 @default.
- W4309211092 cites W2122411629 @default.
- W4309211092 cites W2124672425 @default.
- W4309211092 cites W2129326802 @default.
- W4309211092 cites W2134319114 @default.
- W4309211092 cites W2137712934 @default.
- W4309211092 cites W2140244618 @default.
- W4309211092 cites W2140474152 @default.
- W4309211092 cites W2149060182 @default.
- W4309211092 cites W2151851600 @default.
- W4309211092 cites W2153504598 @default.
- W4309211092 cites W2164237992 @default.
- W4309211092 cites W2309492117 @default.
- W4309211092 cites W2412101175 @default.
- W4309211092 cites W2522665294 @default.
- W4309211092 cites W2532698690 @default.
- W4309211092 cites W2622524621 @default.
- W4309211092 cites W2726705340 @default.
- W4309211092 cites W2731024881 @default.
- W4309211092 cites W2735815044 @default.
- W4309211092 cites W2749302177 @default.
- W4309211092 cites W2751073142 @default.
- W4309211092 cites W2912819401 @default.
- W4309211092 cites W2938427429 @default.
- W4309211092 cites W2944067073 @default.
- W4309211092 cites W3001691617 @default.
- W4309211092 cites W3012656501 @default.
- W4309211092 cites W3153531740 @default.
- W4309211092 cites W3163189746 @default.
- W4309211092 doi "https://doi.org/10.3390/ijms232214039" @default.
- W4309211092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36430518" @default.
- W4309211092 hasPublicationYear "2022" @default.
- W4309211092 type Work @default.
- W4309211092 citedByCount "2" @default.
- W4309211092 countsByYear W43092110922023 @default.
- W4309211092 crossrefType "journal-article" @default.
- W4309211092 hasAuthorship W4309211092A5003642180 @default.
- W4309211092 hasAuthorship W4309211092A5009687649 @default.
- W4309211092 hasAuthorship W4309211092A5021580042 @default.
- W4309211092 hasAuthorship W4309211092A5026923125 @default.
- W4309211092 hasAuthorship W4309211092A5029379615 @default.
- W4309211092 hasAuthorship W4309211092A5059828833 @default.
- W4309211092 hasAuthorship W4309211092A5069729257 @default.
- W4309211092 hasAuthorship W4309211092A5070440854 @default.
- W4309211092 hasAuthorship W4309211092A5078998685 @default.
- W4309211092 hasBestOaLocation W43092110921 @default.
- W4309211092 hasConcept C126322002 @default.
- W4309211092 hasConcept C134018914 @default.
- W4309211092 hasConcept C170493617 @default.
- W4309211092 hasConcept C198710026 @default.
- W4309211092 hasConcept C207865475 @default.
- W4309211092 hasConcept C2776885963 @default.